ATARA BIOTHERAPEUTICS, INC. Operating Income
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Operating Income of -$4.72 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-12
- ATARA BIOTHERAPEUTICS, INC. operating income (loss) for the quarter ending 2026-06-30 was -$4.72M, a 247.64% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. operating income (loss) for the quarter ending 2026-03-31 was -$3.37M, a 108.68% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. operating income (loss) for the quarter ending 2025-12-31 was -$2.56M.
- ATARA BIOTHERAPEUTICS, INC. operating income (loss) for the quarter ending 2025-09-30 was -$3.57M.
- ATARA BIOTHERAPEUTICS, INC. operating income (loss) for fiscal 2025 was $35.86M.
- ATARA BIOTHERAPEUTICS, INC. operating income (loss) for fiscal 2024 was -$83.44M.
- ATARA BIOTHERAPEUTICS, INC. operating income (loss) for fiscal 2023 was -$276.01M.
- ATARA BIOTHERAPEUTICS, INC. operating income (loss) for fiscal 2022 was -$280.51M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 4 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$4.72M 10-Q · filed 2026-08-12 | -$8.09M 10-Q · filed 2026-08-12 | -$10.65M derived: sum of 3 quarters · filed 2026-08-12 | -$14.23M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | -$3.37M 10-Q · filed 2026-05-12 | -$5.93M derived: sum of 2 quarters · filed 2026-05-12 | -$9.51M derived: sum of 3 quarters · filed 2026-05-12 | -$6.31M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-12-31 | -$2.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$6.14M derived: sum of 2 quarters · filed 2026-03-16 | -$2.94M derived: sum of 3 quarters · filed 2026-08-12 | $35.86M 10-K · filed 2026-03-16 | |
| 2025-09-30 | -$3.57M 10-Q · filed 2025-11-12 | -$377.00K derived: sum of 2 quarters · filed 2026-08-12 | $38.42M 10-Q · filed 2025-11-12 | $26.22M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-06-30 | $3.20M 10-Q · filed 2026-08-12 | $42.00M 10-Q · filed 2026-08-12 | $29.80M derived: sum of 3 quarters · filed 2026-08-12 | $8.04M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | $38.80M 10-Q · filed 2026-05-12 | $26.60M derived: sum of 2 quarters · filed 2026-05-12 | $4.84M derived: sum of 3 quarters · filed 2026-05-12 | -$13.39M derived: sum of 4 quarters · filed 2026-05-12 | |
| 2024-12-31 | -$12.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$33.96M derived: sum of 2 quarters · filed 2026-03-16 | -$52.19M derived: sum of 3 quarters · filed 2026-03-16 | -$83.44M 10-K · filed 2026-03-16 | |
| 2024-09-30 | -$21.76M 10-Q · filed 2025-11-12 | -$39.99M derived: sum of 2 quarters · filed 2025-11-12 | -$71.23M 10-Q · filed 2025-11-12 | -$131.20M derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | -$18.23M 10-Q · filed 2025-08-11 | -$49.48M 10-Q · filed 2025-08-11 | -$109.44M derived: sum of 3 quarters · filed 2025-08-11 | -$179.05M derived: sum of 4 quarters · filed 2025-08-11 | |
| 2024-03-31 | -$31.25M 10-Q · filed 2025-05-15 | -$91.21M derived: sum of 2 quarters · filed 2025-05-15 | -$160.82M derived: sum of 3 quarters · filed 2025-05-15 | -$232.24M derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | -$59.96M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -$129.57M derived: sum of 2 quarters · filed 2025-03-07 | -$200.99M derived: sum of 3 quarters · filed 2025-03-07 | -$276.01M 10-K · filed 2025-03-07 | |
| 2023-09-30 | -$69.61M 10-Q · filed 2024-11-12 | -$141.03M derived: sum of 2 quarters · filed 2024-11-12 | -$216.04M 10-Q · filed 2024-11-12 | -$291.58M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | -$71.41M 10-Q · filed 2024-08-12 | -$146.43M 10-Q · filed 2024-08-12 | -$221.97M derived: sum of 3 quarters · filed 2024-08-12 | -$306.59M derived: sum of 4 quarters · filed 2024-08-12 | |
| 2023-03-31 | -$75.02M 10-Q · filed 2024-05-09 | -$150.56M derived: sum of 2 quarters · filed 2024-05-09 | -$235.18M derived: sum of 3 quarters · filed 2024-05-09 | -$267.31M derived: sum of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | -$75.54M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$160.16M derived: sum of 2 quarters · filed 2024-03-28 | -$192.29M derived: sum of 3 quarters · filed 2024-03-28 | -$280.51M 10-K · filed 2024-03-28 | |
| 2022-09-30 | -$84.62M 10-Q · filed 2023-11-01 | -$116.75M derived: sum of 2 quarters · filed 2023-11-01 | -$204.97M 10-Q · filed 2023-11-01 | -$298.38M derived: sum of 4 quarters · filed 2023-11-01 | |
| 2022-06-30 | -$32.13M 10-Q · filed 2023-08-08 | -$120.35M 10-Q · filed 2023-08-08 | -$213.75M derived: sum of 3 quarters · filed 2023-08-08 | -$298.57M derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-03-31 | -$88.22M 10-Q · filed 2023-05-08 | -$181.62M derived: sum of 2 quarters · filed 2023-05-08 | -$266.44M derived: sum of 3 quarters · filed 2023-05-08 | -$350.44M derived: sum of 4 quarters · filed 2023-05-08 | |
| 2021-12-31 | -$93.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-08 | -$178.22M derived: sum of 2 quarters · filed 2023-02-08 | -$262.22M derived: sum of 3 quarters · filed 2023-02-08 | -$340.46M 10-K · filed 2023-02-08 | |
| 2021-09-30 | -$84.81M 10-Q · filed 2022-11-08 | -$168.81M derived: sum of 2 quarters · filed 2022-11-08 | -$247.06M 10-Q · filed 2022-11-08 | -$328.76M derived: sum of 4 quarters · filed 2023-02-08 | |
| 2021-06-30 | -$84.00M 10-Q · filed 2022-08-08 | -$162.25M 10-Q · filed 2022-08-08 | -$243.94M derived: sum of 3 quarters · filed 2023-02-08 | -$318.65M derived: sum of 4 quarters · filed 2023-02-08 | |
| 2021-03-31 | -$78.25M 10-Q · filed 2022-05-05 | -$159.94M derived: sum of 2 quarters · filed 2023-02-08 | -$234.65M derived: sum of 3 quarters · filed 2023-02-08 | -$312.60M derived: sum of 4 quarters · filed 2023-02-08 | |
| 2020-12-31 | -$81.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-08 | -$156.40M derived: sum of 2 quarters · filed 2023-02-08 | -$234.35M derived: sum of 3 quarters · filed 2023-02-08 | -$309.05M 10-K · filed 2023-02-08 | |
| 2020-09-30 | -$74.71M 10-Q · filed 2021-11-04 | -$152.66M derived: sum of 2 quarters · filed 2021-11-04 | -$227.35M 10-Q · filed 2021-11-04 | -$307.05M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-06-30 | -$77.95M 10-Q · filed 2021-08-09 | -$152.65M 10-Q · filed 2021-08-09 | -$232.35M derived: sum of 3 quarters · filed 2022-02-28 | -$304.90M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-03-31 | -$74.70M 10-Q · filed 2021-05-04 | -$154.40M derived: sum of 2 quarters · filed 2022-02-28 | -$226.95M derived: sum of 3 quarters · filed 2022-02-28 | -$302.49M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2019-12-31 | -$79.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$152.25M derived: sum of 2 quarters · filed 2022-02-28 | -$227.79M derived: sum of 3 quarters · filed 2022-02-28 | -$295.68M 10-K · filed 2022-02-28 | |
| 2019-09-30 | -$72.56M 10-Q · filed 2020-11-09 | -$148.09M derived: sum of 2 quarters · filed 2020-11-09 | -$215.98M 10-Q · filed 2020-11-09 | -$297.80M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-06-30 | -$75.53M 10-Q · filed 2020-08-05 | -$143.43M 10-Q · filed 2020-08-05 | -$225.24M derived: sum of 3 quarters · filed 2021-03-01 | -$285.46M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-03-31 | -$67.89M 10-Q · filed 2020-05-06 | -$149.71M derived: sum of 2 quarters · filed 2021-03-01 | -$209.93M derived: sum of 3 quarters · filed 2021-03-01 | -$262.55M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2018-12-31 | -$81.82M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$142.04M derived: sum of 2 quarters · filed 2021-03-01 | -$194.66M derived: sum of 3 quarters · filed 2021-03-01 | -$237.11M 10-K · filed 2021-03-01 | |
| 2018-09-30 | -$60.22M 10-Q · filed 2019-11-07 | -$112.84M derived: sum of 2 quarters · filed 2019-11-07 | -$155.29M 10-Q · filed 2019-11-07 | -$191.10M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-06-30 | -$52.62M 10-Q · filed 2019-08-08 | -$95.08M 10-Q · filed 2019-08-08 | -$130.88M derived: sum of 3 quarters · filed 2020-02-27 | -$162.54M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-03-31 | -$42.45M 10-Q · filed 2019-05-09 | -$78.25M derived: sum of 2 quarters · filed 2020-02-27 | -$109.91M derived: sum of 3 quarters · filed 2020-02-27 | -$137.82M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2017-12-31 | -$35.80M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$67.46M derived: sum of 2 quarters · filed 2020-02-27 | -$95.37M derived: sum of 3 quarters · filed 2020-02-27 | -$121.53M 10-K · filed 2020-02-27 | |
| 2017-09-30 | -$31.66M 10-Q · filed 2018-11-06 | -$59.57M derived: sum of 2 quarters · filed 2018-11-06 | -$85.73M 10-Q · filed 2018-11-06 | -$104.48M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2017-06-30 | -$27.91M 10-Q · filed 2018-08-01 | -$54.07M 10-Q · filed 2018-08-01 | -$72.82M derived: sum of 3 quarters · filed 2019-02-26 | -$98.77M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2017-03-31 | -$26.16M 10-Q · filed 2018-05-08 | -$44.91M derived: sum of 2 quarters · filed 2019-02-26 | -$70.86M derived: sum of 3 quarters · filed 2019-02-26 | -$90.34M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2016-12-31 | -$18.75M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$44.70M derived: sum of 2 quarters · filed 2019-02-26 | -$64.18M derived: sum of 3 quarters · filed 2019-02-26 | -$81.24M 10-K · filed 2019-02-26 | |
| 2016-09-30 | -$25.94M 10-Q · filed 2017-11-09 | -$45.43M derived: sum of 2 quarters · filed 2017-11-09 | -$62.49M 10-Q · filed 2017-11-09 | -$84.26M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-06-30 | -$19.48M 10-Q · filed 2017-08-07 | -$36.55M 10-Q · filed 2017-08-07 | -$58.32M derived: sum of 3 quarters · filed 2018-02-27 | -$70.58M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-03-31 | -$17.06M 10-Q · filed 2017-05-04 | -$38.83M derived: sum of 2 quarters · filed 2018-02-27 | -$51.09M derived: sum of 3 quarters · filed 2018-02-27 | -$66.20M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2015-12-31 | -$21.77M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$34.03M derived: sum of 2 quarters · filed 2018-02-27 | -$49.14M derived: sum of 3 quarters · filed 2018-02-27 | -$58.45M 10-K · filed 2018-02-27 | |
| 2015-09-30 | -$12.26M 10-Q · filed 2016-11-04 | -$27.37M derived: sum of 2 quarters · filed 2016-11-04 | -$36.68M 10-Q · filed 2016-11-04 | -$47.27M derived: sum of 4 quarters · filed 2017-03-09 | |
| 2015-06-30 | -$15.11M 10-Q · filed 2016-08-08 | -$24.42M 10-Q · filed 2016-08-08 | -$35.02M derived: sum of 3 quarters · filed 2017-03-09 | -$40.96M derived: sum of 4 quarters · filed 2017-03-09 | |
| 2015-03-31 | -$9.31M 10-Q · filed 2016-05-06 | -$19.91M derived: sum of 2 quarters · filed 2017-03-09 | -$25.86M derived: sum of 3 quarters · filed 2017-03-09 | -$30.39M derived: sum of 4 quarters · filed 2017-03-09 | |
| 2014-12-31 | -$10.60M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | -$16.55M derived: sum of 2 quarters · filed 2017-03-09 | -$21.08M derived: sum of 3 quarters · filed 2017-03-09 | -$28.16M 10-K · filed 2017-03-09 | |
| 2014-09-30 | -$5.95M 10-Q · filed 2015-11-06 | -$10.48M derived: sum of 2 quarters · filed 2015-11-06 | -$17.56M 10-Q · filed 2015-11-06 | -$20.98M derived: sum of 4 quarters · filed 2016-03-04 | |
| 2014-06-30 | -$4.53M 10-Q · filed 2015-08-07 | -$11.61M 10-Q · filed 2015-08-07 | -$15.03M derived: sum of 3 quarters · filed 2016-03-04 | -$17.58M derived: sum of 4 quarters · filed 2016-03-04 | |
| 2014-03-31 | -$7.08M 10-Q · filed 2015-05-11 | -$10.49M derived: sum of 2 quarters · filed 2016-03-04 | -$13.05M derived: sum of 3 quarters · filed 2016-03-04 | ||
| 2013-12-31 | -$3.42M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-04 | -$5.97M derived: sum of 2 quarters · filed 2016-03-04 | -$8.62M 10-K · filed 2016-03-04 | ||
| 2013-09-30 | -$2.55M 10-Q · filed 2014-11-12 | -$5.20M 10-Q · filed 2014-11-12 | |||
| 2012-12-31 | -$4.09M 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |